Granules III
Completed · India
Source: International Finance Corporation (IFC)
Granules India Limited (“Granules” or the “Company”) – an existing IFC client - is an Indian pharmaceutical company engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages (FDs) of a variety of drugs, including over-the-counter ones. The Company sells its products mainly in the US, Europe, Latin America and Indi
- Status
- Closed
- Sector
- Water Supply and Storage, Hospital, Manufacturing (Industrial), Commercial, Waste Processing and Treatment, Warehouse, Government
- Location
- India
- Updated
- 22 Jul 2026
- Source
- International Finance Corporation (IFC)
ConstructChat
Ask ConstructChat about Granules III
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
Sponsoring Agency |
Status
Original status | completed |
Taiyo status | Closed |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | Granules India Limited (“Granules” or the “Company”) – an existing IFC client - is an Indian pharmaceutical company engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages (FDs) of a variety of drugs, including over-the-counter ones. The Company sells its products mainly in the US, Europe, Latin America and India. Granules has wholly-owned manufacturing plants near Hyderabad in India (Jeedimetla, Bonthapally, and Gagillapur) and in Vishakhapatnam, India along with a R&D and manufacturing facility in Virginia, USA Further, through its joint ventures, it has one plant in China and yet another manufacturing plant in Vishakhapatnam, India. . The Company is undertaking an investment program directed towards setting up new capacity, expanding existing capacities and investing in R&D to improve its product mix in favor of higher value-added products. A large part of the investment program is in the form of capital expenditures in India (the “Project”), which is estimated to cost about US$84 million. The Project includes building a greenfield API manufacturing facility in Vishakhapatnam, India, expanding existing API and PFI capacities, investment in R&D, quality assurance ("QA”), and quality control("QC”), investment in other general capital expenditures at existing facilities, and additional warehouse capacity. |
Original sector | G-FA - Pharmaceuticals and Medicine |
Budget |
Location
Country | India |
Source
Source | International Finance Corporation (IFC) |
URL |
More Details
Record type | Project |
Sector | Water Supply and Storage, Hospital, Manufacturing (Industrial), Commercial, Waste Processing and Treatment, Warehouse, Government |
Article published date | 2025-10-16 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
More Water Supply and Storage projects in India
- Kiru Hydroelectric Project Jammu and Kashmir India
- Pinnapuram Integrated Renewable Energy Project India
- Chuzachen Hydroelectric Power Project Sikkim
- Mahan I Power Project Madhya Pradesh
- Rampur Hydro Electric Power Project Himachal Pradesh
- UriII Hydroelectric Project Jammu and Kashmir
- Kakrapar Atomic Power Station Expansion
- Nathpa Jhakri India Hydroelectric Power Plant
